Sara Lonardi - Istituto Oncologico Veneto

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 218 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Management of Portal Hypertension in Patients Receiving Atezolizumab-Bevacizumab for Hepatocellular Carcinoma

F. Tovoli,E. Franceschini,C. Vivaldi,P. Federico,A. Palloni,A. Dalbeni,C. Solda,B. Stefanini,I. Garajova,L. Ielasi,S. De Lorenzo,A. Granito, R. Chen,G. Masi,S. Lonardi,G. Brandi,B. Daniele,D. Sacerdoti,L. Lani,G. Svegliati-Baroni, C. Campani, F. Piscaglia

DIGESTIVE AND LIVER DISEASE (2024): S87-S87

引用0浏览0引用

66P Targeted treatment (TT) after immune checkpoint inhibitors (ICIs) in BRAF V600E mutated (BRAFm) and deficient mismatch repair or microsatellite instability high (dMMR/MSI-H) metastatic colorectal cancer (mCRC)

M. Ambrosini,D. Tougeron,D.P. Modest,R. Guimbaud,S. Kopetz, M. Decraecker,F. Sclafani,C. Coutzac,A. Lievre, E.L. Alouani,F. Marmorino,S. Pernot,F.A. Sinicrope,M.E. Elez Fernandez,M.M. Germani,F. Pietrantonio,S. Lonardi, P. Parent,C. Gallois,J. Taieb

Annals of Oncology (2024)

引用0浏览0引用

Impact of Metformin, Statin, Aspirin and Insulin on the Prognosis of Uhcc Patients Receiving First Line Lenvatinib or Atezolizumab Plus Bevacizumab

SCIENTIFIC REPORTSno. 1 (2024)

引用0浏览0WOSNATURE引用

Efficacy and Safety of Atezolizumab/bevacizumab for Hepatocellular Carcinoma in a Real-Life Prospective Cohort: Data from a Multicenter Collaborative Study

F. Tovoli,C. Vivaldi,P. Federico,B. Stefanini,A. Palloni,A. Dalbeni,C. Solda,L. Lani,I. Garajova,S. Tamberi,S. De Lorenzo,A. Granito, D. P. Pallotta,G. Masi,S. Lonardi,G. Brandi,B. Daniele,D. Sacerdoti,G. Svegliati-Baroni, C. Campani, E. Pellegrini, F. Piscaglia

DIGESTIVE AND LIVER DISEASE (2024): S85-S86

引用0浏览0引用

Treatment of Patients with BRAFV600E-mutated Metastatic Colorectal Cancer after Progression to Encorafenib and Cetuximab: Data from a Real-World Nationwide Dataset

M. M. Germani,G. Vetere, F. Santamaria,R. Intini,F. Ghelardi,M. Bensi,A. Boccaccino,A. Minelli,M. Carullo,P. Ciraci,A. Passardi, S. Santucci,R. Giampieri,M. Persano,E. Fenocchio,A. Puccini,S. Lonardi,F. Pietrantonio, L. Salvatere,C. Cremolini

ESMO OPENno. 4 (2024)

引用0浏览0WOS引用

Comparative Efficacy of PD-1 Blockade in Patients with Dmmr/msi-H Metastatic Colorectal or Gastric Cancer: a Global Retrospective Study

G. Mazzoli,F. Nichetti,K. Shitara, R. Cohen,S. Lonardi,C. Cremolini, M.E. Elez, J. Chao,M. Fakih,S.J. Klempner,P. Jayachandran,S. Maron,D. Cowzer,L. Fornaro,L. Salvatore, V. Zhu, Y. Aoki,R. Cerantola,F. Bergamo,M. Salati

ESMO Gastrointestinal Oncology (2024): 100037

引用0浏览0引用

Aetiology of Hepatocellular Carcinoma and Response to Immunotherapy: is the Problem Inherent in the Classification of Non-Viral Disease

F. Tovoli, R. Chen,C. Vivaldi,P. Federico,A. Palloni,L. A. Natola,C. Solda,B. Stefanini,I. Garajova,L. Ielasi,S. De Lorenzo,A. Granito, G. Monaco,G. Masi,S. Lonardi,G. Brandi,B. Daniele,A. Dalbeni,L. Lani,G. Svegliati-Baroni, C. Campani, F. Piscaglia

DIGESTIVE AND LIVER DISEASE (2024): S92-S93

引用0浏览0引用

The Impact of Etiology on Patterns of Progression of Advanced HCC

B. Stefanini,F. Piscaglia,A. Dalbeni,C. Vivaldi,P. Federico,A. Palloni,C. Solda,I. Garajova,L. Ielasi,S. De Lorenzo,G. Masi,S. Lonardi,G. Brandi,B. Daniele,F. Trevisani,G. Svegliati-Baroni,C. Campani, R. Chen,F. Tovoli

DIGESTIVE AND LIVER DISEASE (2024): S17-S17

引用0浏览0引用

Immune Checkpoint Inhibitors for POLE or POLD1 Proofreading-Deficient Metastatic Colorectal Cancer

M. Ambrosini,B. Rousseau,P. Manca, O. Artz,A. Marabelle,T. Andre,G. Maddalena, G. Mazzoli,R. Intini, R. Cohen,A. Cercek,N. H. Segal,L. Saltz,A. M. Varghese,R. Yaeger,M. Nusrat, Z. Goldberg,G. Y. Ku, I. El Dika,O. Margalit,A. Grinshpun, P. Murtaza Kasi,R. Schilsky, A. Lutfi,E. Shacham-Shmueli, M. Khan Afghan, L. Weiss,C. B. Westphalen,V. Conca,B. Decker,G. Randon,E. Elez,M. Fakih,A. B. Schrock,C. Cremolini,P. Jayachandran,M. J. Overman,S. Lonardi,F. Pietrantonio

ANNALS OF ONCOLOGYno. 7 (2024): 643-655

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn